DIA
ANIK icon

Denver Investment Advisors’s Anika Therapeutics ANIK Stock Holding History

Denver Investment Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-5,749
Closed -$237K – 560
2015
Q1 		$237K Sell
5,749
-124
-2% -$5.01K 0.01% 535
2014
Q4 		$239K Buy
5,873
+25
+0.4% +$977 0.01% 523
2014
Q3 		$214K Buy
5,848
+330
+6% +$14.3K 0.01% 522
2014
Q2 		$256K Hold
5,518
– – 0.01% 489
2014
Q1 		$227K Buy
+5,518
New +$205K 0.01% 531

Other funds holding ANIK

TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
LCP
Lombardia Capital Partners Pasadena, California $110M AUM 13.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.57B AUM 19.49% 1-Year Est. Return

Denver Investment Advisors's ANIK Position: Q2 2015 in Review

Denver Investment Advisors sold out of Anika Therapeutics (ANIK) in Q2 2015, closing a stake of 5,749 shares — an estimated $237K sold.

Denver Investment Advisors first reported a position in ANIK in Q1 2014 and held it in 5 quarters. The position peaked at $256K in Q2 2014. 136 funds tracked by Wall St. Rank hold ANIK as of Q2 2015.

  • Denver Investment Advisors reported no remaining Anika Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Denver Investment Advisors sold 5,749 Anika Therapeutics shares in Q2 2015, an estimated $237K.
  • Denver Investment Advisors first reported a position in Anika Therapeutics in Q1 2014 and held it in 5 quarters.
  • Denver Investment Advisors's Anika Therapeutics position peaked at $256K in Q2 2014.
  • 136 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2015.

Based on Denver Investment Advisors's 13F filing for Q2 2015, filed 10 Aug 2015.